Work

Alliance A041701 - a Randomized Phase 2/3 Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia (AML) Receiving Intensive Induction Chemotherapy

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-127142

Authors: Geoffrey L. Uy, Jun Yin, Heidi D. Klepin, Shira Dinner, Anthony J. Jaslowski, Stephen A. Strickland, Jane L. Liesveld, John C. Byrd, Richard M. Stone

Institutions: Washington University in St. Louis, Mayo Clinic, Wake Forest University Health Sciences, Wake Forest University, Northwestern University, Vanderbilt University Medical Center, University of Rochester Medicine, University of Rochester, The Ohio State University, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2985517355

Cites:

Cited by: 2

Related to: 10